YUKA MORIKAWA to Mineralocorticoid Receptor Antagonists
This is a "connection" page, showing publications YUKA MORIKAWA has written about Mineralocorticoid Receptor Antagonists.
Connection Strength
0.316
-
Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker. Hypertens Res. 2020 11; 43(11):1204-1213.
Score: 0.167
-
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. Eur J Pharmacol. 2015 Aug 15; 761:226-34.
Score: 0.117
-
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats. J Pharmacol Exp Ther. 2016 09; 358(3):548-57.
Score: 0.032